Pulmonx Corporation logo

Pulmonx Corporation Funding & Investors

Pulmonx Corporation develops and markets medical devices. The Company provides products for diagnosis and treatment of pulmonary disorders. Pulmonx operates worldwide.

pulmonx.com

Total Amount Raised: $276,924,992

Pulmonx Corporation Funding Rounds

  • Debt Financing

    $17,000,000

    Debt Financing Investors

    CIBC Innovation Banking
  • Debt Financing

    $17,000,000

    Debt Financing Investors

    CIBC Innovation Banking
  • Series H

    $66,000,000

    Series H Investors

    Partner Fund Management
    Ally Bridge Group
    HealthQuest Capital
    Adage Capital Management
    Rock Springs Capital
  • Series G

    $65,000,000

    Series G Investors

    RTW Investments
    Latterell Venture Partners
    Ally Bridge Group
    ArrowMark Partners
    Boston Scientific
    Driehaus Capital Management
    Montreux Equity Partners
  • Series H

    $66,000,000

    Series H Investors

    Partner Fund Management
    Ally Bridge Group
    HealthQuest Capital
    Adage Capital Management
    Rock Springs Capital
  • Series G

    $65,000,000

    Series G Investors

    RTW Investments
    Latterell Venture Partners
    Ally Bridge Group
    ArrowMark Partners
    Boston Scientific
    Driehaus Capital Management
    Montreux Equity Partners
  • Series C

    $32,000,000

    Series C Investors

    Latterell Venture Partners
    HealthCap
    MedVenture Associates
    De Novo Ventures
    Kleiner Perkins Caufield & Byers
    POSCO BioVentures
    Montreux Equity Partners
  • Series F

    $30,000,000

    Series F Investors

    Boston Scientific
  • Private Equity

    $10,000,000

    Private Equity Investors

    Latterell Venture Partners
    MedVenture Associates
    De Novo Ventures
    Kleiner Perkins Caufield & Byers
    Montreux Equity Partners
  • Debt Financing

    $20,000,000

    Debt Financing Investors

    Oxford Finance
  • Series B

    $20,000,000

    Series B Investors

    Latterell Venture Partners
    De Novo Ventures
    MedVenture Associates
    Montreux Equity Partners
  • Series F

    $30,000,000

    Series F Investors

    Boston Scientific
  • Debt Financing

    $20,000,000

    Debt Financing Investors

    Oxford Finance
  • Private Equity

    $10,000,000

    Private Equity Investors

    Latterell Venture Partners
    MedVenture Associates
    De Novo Ventures
    Kleiner Perkins Caufield & Byers
    Montreux Equity Partners
  • Series C

    $32,000,000

    Series C Investors

    Latterell Venture Partners
    HealthCap
    MedVenture Associates
    De Novo Ventures
    Kleiner Perkins Caufield & Byers
    POSCO BioVentures
    Montreux Equity Partners
  • Series Unknown

    $2,856,000

  • Debt Financing

    $7,010,000

  • Series Unknown

    $2,856,000

  • Debt Financing

    $7,010,000

  • Series A

    $7,059,000

    Series A Investors

    MedVenture Associates
    Montreux Equity Partners
Funding info provided by Diffbot.